Sign Up to like & get recommendations! 0
Published in 2019 at "Cancer Medicine"
DOI: 10.1002/cam4.2452
Abstract: The pelvis is the most common site of chondrosarcoma (CS), and the prognosis for patients with pelvic CS is worse than that for patients with CS in the extremities. However, clinicians have had few tools… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.5335
Abstract: To explore the factors affecting the prognosis of cervical cancer (CC), and to construct and evaluate predictive nomograms to guide individualized clinical treatment. read more here.
Sign Up to like & get recommendations! 1
Published in 2023 at "Cancer Medicine"
DOI: 10.1002/cam4.5736
Abstract: The aim of this study was to develop and validate systematic nomograms to predict cancer specific survival (CSS) and overall survival (OS) in osteosarcoma patients aged over 60 years. read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Pancreas"
DOI: 10.1097/mpa.0000000000001395
Abstract: OBJECTIVES This study aimed to identify factors affecting outcome of percutaneous catheter drainage (PCD) in management of infected pancreatic necrosis treated with step-up approach. METHODS This was a single-center retrospective cohort study that included patients… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Journal of Clinical Pathology"
DOI: 10.1136/jcp-2021-208064
Abstract: Aims To develop and verify pathological models using pathological features basing on HE images to predict survival invasive endocervical adenocarcinoma (ECA) postoperatively. Methods There are 289 ECA patients were classified into training and validation cohort.… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Annals of Surgical Oncology"
DOI: 10.1245/s10434-021-11225-1
Abstract: Significant variability across more than 100 distinct soft tissue sarcoma (STS) histologic subtypes has made traditional TNM classification challenging and has historically hampered the prognostic applicability of the American Joint Committee on Cancer (AJCC) staging… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Future oncology"
DOI: 10.2217/fon-2020-1065
Abstract: Background: Hepatocellular carcinoma (HCC) is one of the most common malignant tumors. The existing staging system has a limited budget capacity for HCC recurrence. The authors aimed to establish and verify two nomogram models to predict… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.989366
Abstract: Background Myeloid sarcoma (MS) is a rare hematological tumor that presents with extramedullary tumor masses comprising myeloid blasts. A controversial issue is whether MS involving normal hematopoietic sites (liver, spleen, and lymph nodes) should be… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Cancers"
DOI: 10.3390/cancers11101435
Abstract: Despite consistent evidence that comorbidities and functional status (FS) are strong prognostic factors for colorectal cancer (CRC) patients, these important characteristics are not considered in prognostic nomograms. We assessed to what extent incorporating these characteristics… read more here.